Is Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High‐Risk Adults Possible?

Edward E. Walsh; Derick R. Peterson; Ann R. Falsey

doi:10.1086/511986

Is Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High‐Risk Adults Possible?

The Journal of Infectious Diseases ◽

10.1086/511986 ◽

2007 ◽

Vol 195 (7) ◽

pp. 1046-1051 ◽

Cited By ~ 66

Author(s):

Edward E. Walsh ◽

Derick R. Peterson ◽

Ann R. Falsey

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Hospitalized Elderly ◽

Syncytial Virus

Download Full-text

Faculty Opinions recommendation of Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13356007.14726117 ◽

2011 ◽

Author(s):

Daniel Sloniewsky

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Literature Review ◽

Respiratory Syncytial Virus Infection ◽

Systematic Literature Review ◽

Meta Analysis ◽

Severe Respiratory Syncytial Virus ◽

Mortality And Morbidity ◽

Syncytial Virus

Download Full-text

Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants

Italian Journal of Pediatrics ◽

10.1186/1824-7288-35-4 ◽

2009 ◽

Vol 35 (1) ◽

pp. 4 ◽

Cited By ~ 21

Author(s):

Gaetano Chirico ◽

Roberto Ravasio ◽

Urbano Sbarigia

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Simulation Model ◽

Preterm Infants ◽

Respiratory Syncytial Virus Infection ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Syncytial Virus

Download Full-text

Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

New England Journal of Medicine ◽

10.1056/nejmoa043951 ◽

2005 ◽

Vol 352 (17) ◽

pp. 1749-1759 ◽

Cited By ~ 1087

Author(s):

Ann R. Falsey ◽

Patricia A. Hennessey ◽

Maria A. Formica ◽

Christopher Cox ◽

Edward E. Walsh

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus

Download Full-text

The role of RSV neutralizing antibodies in the treatment and prevention of respiratory syncytial virus infection in high-risk children

Antiviral Research ◽

10.1016/0166-3542(94)90028-0 ◽

1994 ◽

Vol 23 (1) ◽

pp. 1-10 ◽

Cited By ~ 11

Author(s):

Jessie R. Groothuis

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Neutralizing Antibodies ◽

Treatment And Prevention ◽

Syncytial Virus ◽

High Risk Children

Download Full-text

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort

Archives of Disease in Childhood ◽

10.1136/adc.83.4.313 ◽

2000 ◽

Vol 83 (4) ◽

pp. 313-316 ◽

Cited By ~ 47

Author(s):

S. J Clark

Keyword(s):

United Kingdom ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Potential Impact ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

PEDIATRICS ◽

10.1542/peds.102.3.531 ◽

1998 ◽

Vol 102 (3) ◽

pp. 531-537 ◽

Cited By ~ 1251

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Editorial - Respiratory Syncytial Virus Infection in High-Risk Infants

The Open Microbiology Journal ◽

10.2174/1874285801105010127 ◽

2011 ◽

Vol 5 (1) ◽

pp. 127-127

Author(s):

Bernhard Resch

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e318235455b ◽

2012 ◽

Vol 31 (1) ◽

pp. e1-e8 ◽

Cited By ~ 45

Author(s):

Bernhard Resch ◽

Constanze Sommer ◽

Mark J. C. Nuijten ◽

Susanne Seidinger ◽

Evelyn Walter ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

Cost Effectiveness ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Epidemiologic Data ◽

Syncytial Virus ◽

High Risk Children

Download Full-text

RESPIRATORY DISEASE: Respiratory syncytial virus infection in elderly, high-risk, and hospitalized adults

Postgraduate Medicine ◽

10.3810/pgm.2005.09.1832 ◽

2005 ◽

Vol 118 (3) ◽

pp. 8-8

Author(s):

Tamar F. Barlam

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Disease ◽

Respiratory Syncytial Virus Infection ◽

Syncytial Virus

Download Full-text

Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan

Pediatrics International ◽

10.1111/j.1442-200x.2010.03249.x ◽

2011 ◽

Vol 53 (3) ◽

pp. 368-373 ◽

Cited By ~ 8

Author(s):

Satoshi Kusuda ◽

Naoto Takahashi ◽

Takami Saitoh ◽

Masaru Terai ◽

Hisashi Kaneda ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

High Risk ◽

Virus Infection ◽

Respiratory Syncytial Virus Infection ◽

Pediatric Ward ◽

Syncytial Virus ◽

High Risk Infants

Download Full-text